Home Curocell

Curocell

In operation
-
Developer of Anti-Cancer Immune Cell Therapy

Basic Information

Curocell is developing innovative anticancer drugs using genetically engineered immune cells. Curocell's technology is continuously evolving with the goal of treating various types of cancer. Curocell's OVIS™ technology enhances immune cells to overcome immunosuppression in the tumor microenvironment.
Curocell Inc.
Daejeon,DaejeonMetropolitanCity,SouthKorea
unclear
January 01, 2016
contact@curocellbtx.com